Foghorn Therapeutics Inc. (FHTX) Operating Margin % [USD] 2020 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Foghorn Therapeutics Inc. quarterly/annual Operating Margin history and growth rate from 2020 to 2024.
  • Foghorn Therapeutics Inc. Operating Margin for the quarter ending March 31, 2024 was -303 %, a 49% increase year-over-year.
  • Foghorn Therapeutics Inc. annual Operating Margin for 2023 was -316 %, a 48.1% increase from 2022.
  • Foghorn Therapeutics Inc. annual Operating Margin for 2022 was -609 %, a 92% increase from 2021.
  • Foghorn Therapeutics Inc. annual Operating Margin for 2021 was -7.64 K %, a 52.1% increase from 2020.
Operating Margin, Quarterly (% [USD])
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -303 +292 +49% Jan 1, 2024 Mar 31, 2024
Q4 2023 -316 +293 +48.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -351 +368 +51.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -578 +637 +52.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -595 +1.53 K +72% Jan 1, 2023 Mar 31, 2023
Q4 2022 -609 +7.03 K +92% Oct 1, 2022 Dec 31, 2022
Q3 2022 -719 +10.2 K +93.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -1.21 K +7.39 K +85.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 -2.13 K +8.76 K +80.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -7.64 K +8.3 K +52.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 -10.9 K Jul 1, 2021 Sep 30, 2021
Q2 2021 -8.61 K Apr 1, 2021 Jun 30, 2021
Q1 2021 -10.9 K Jan 1, 2021 Mar 31, 2021
Q4 2020 -15.9 K Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.